bf/NASDAQ:TOI_icon.jpeg

NASDAQ:TOI

The Oncology Institute of Hope and Innovation

  • Stock

USD

Last Close

3.81

06/11 22:30

Market Cap

34.62M

Beta: 0.88

Volume Today

1.03M

Avg: 176.28K

PE Ratio

−2.13

PFCF: −3.03

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
2.61
-
2.85
9.33%
1.00
65.04%
0.96
4.07%
cash conversion cycle
20.07
-
13.51
32.69%
17.67
30.76%
58.38
230.45%
cash per share
0.04
-
0.09
145.18%
1.73
1,754.43%
1.01
41.25%
company equity multiplier
1.41
-
2.34
65.82%
1.95
16.44%
2.12
8.31%
days of inventory outstanding
11.31
-
10.55
6.75%
14.49
37.35%
16.87
16.40%
days of payables outstanding
25.85
-
30.63
18.51%
35.02
14.32%
17.07
51.26%
days of sales outstanding
34.61
-
33.59
2.93%
38.20
13.70%
58.58
53.36%
dividend yield
0.03
-
ebit per revenue
0.04
-
-0.02
140.06%
-0.04
157.80%
-0.23
416.83%
-0.29
26.25%
-0.24
16.71%
ebt per ebit
1.01
-
1.00
1.34%
1.81
80.52%
0.25
86.01%
-0.03
110.46%
1.08
4,180.73%
effective tax rate
0.19
-
-0.52
379.23%
0.03
106.34%
0.06
73.91%
0.13
124.23%
-0.00
100.33%
enterprise value multiple
2.03K
-
-62.18
103.07%
-12.82
79.38%
-3.19
75.09%
fixed asset turnover
100.20
-
89.11
11.07%
48.43
45.66%
7.64
84.22%
free cash flow per share
0.17
-
0.04
78.26%
-0.01
128.45%
-0.54
4,968.59%
-0.92
71.35%
-0.55
40.03%
gross profit margin
0.23
-
0.19
17.05%
0.20
2.08%
0.20
2.31%
0.21
2.54%
1
384.68%
interest coverage
3.01K
-
-780.67
125.95%
-23.62
96.97%
-143.31
506.84%
-17.64
87.69%
-11.36
35.58%
inventory turnover
32.26
-
34.60
7.23%
25.19
27.19%
21.64
14.09%
long term debt to capitalization
0.19
-
0.45
-
net income per ebt
0.81
-
1.52
87.68%
0.97
36.58%
0.94
2.54%
0.87
7.63%
1.00
14.86%
net profit margin
0.03
-
-0.03
174.17%
-0.08
195.14%
-0.05
29.52%
0.01
112.19%
-0.26
4,003.72%
operating cash flow per share
0.20
-
0.06
71.41%
0.01
85.94%
-0.49
6,356.82%
-0.85
71.93%
-0.49
41.96%
operating cycle
45.92
-
44.14
3.87%
52.69
19.35%
75.45
43.20%
operating profit margin
0.04
-
-0.02
140.06%
-0.04
157.80%
-0.23
416.83%
-0.29
26.25%
-0.24
16.71%
payables turnover
14.12
-
11.91
15.62%
10.42
12.53%
21.38
105.16%
pretax profit margin
0.04
-
-0.02
139.52%
-0.08
365.38%
-0.06
27.68%
0.01
113.20%
-0.26
3,498.77%
price fair value
14.81
-
24.77
67.29%
6.20
74.97%
0.96
84.46%
receivables turnover
10.55
-
10.87
3.01%
9.56
12.05%
6.23
34.79%
return on assets
-0.07
-
-0.22
222.69%
-0.05
75.36%
0.01
111.70%
return on capital employed
-0.06
-
-0.22
285.34%
-0.26
19.49%
-0.31
16.57%
return on equity
-0.10
-
-0.51
435.08%
-0.10
79.41%
0.01
112.67%
total debt to capitalization
0.30
-
0.00
99.41%
0.46
26,388.54%

All numbers in USD (except ratios and percentages)